Diana L. Christian

Diana L. Christian

Auto-generated profile, based on publicly available information

Diana L. Christian

Department of Neuroscience, Washington University School of Medicine

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2012 in Disease Models & Mechanisms
Verified
Journal Article
Open access
DKDavid M. Katz
David M. Katz
JBJoanne E. Berger-Sweeney
Joanne E. Berger-Sweeney
JEJames H Eubanks
James H Eubanks
MJMonica J. Justice
Monica J. Justice
JNJeffrey Lorenz Neul
Jeffrey Lorenz Neul
LMLaura A. Mamounas
Laura A. Mamounas
In September of 2011, the National Institute of Neurological Disorders and Stroke (NINDS), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the International Rett Syndrome Foundation (IRSF) and the Rett Syndrome Research Trust (RSRT) convened a workshop involving a broad cross-section of basic scientists, clinicians and representatives from the National Institutes of Health (NIH), the US Food and Drug Administration (FDA), the pharmaceutical industry and private foundations to assess the state of the art in animal studies of Rett syndrome (RTT). The aim of the workshop was to identify crucial knowledge gaps and to suggest scientific priorities and best practices for the use of animal models in preclinical evaluation of potential new RTT therapeutics. This review summarizes outcomes from the workshop and extensive follow-up discussions among participants, and includes: (1) a comprehensive summary of the physiological and behavioral phenotypes of RTT mouse models to date, and areas in which further phenotypic analyses are required to enhance the utility of these models for translational studies; (2) discussion of the impact of genetic differences among mouse models, and methodological differences among laboratories, on the expression and analysis, respectively, of phenotypic traits; and (3) definitions of the standards that the community of RTT researchers can implement for rigorous preclinical study design and transparent reporting to ensure that decisions to initiate costly clinical trials are grounded in reliable preclinical data.

3 October 2012 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
MKMiriam Kron
Miriam Kron
CHC. James Howell
C. James Howell
IAIan T. Adams
Ian T. Adams
MRMichael Ransbottom
Michael Ransbottom
DCDiana Christian
Diana Christian
DKDavid M. Katz
David M. Katz
Excitatory-inhibitory imbalance has been identified within specific brain microcircuits in models of Rett syndrome (RTT) and other autism spectrum disorders (ASDs). However, macrocircuit dysfunction across the RTT brain as a whole has not been defined. To approach this issue, we mapped expression of the activity-dependent, immediate-early gene product Fos in the brains of wild-type (Wt) and methyl-CpG-binding protein 2 (Mecp2)-null (Null) mice, a model of RTT, before and after the appearance of overt symptoms (3 and 6 weeks of age, respectively). At 6 weeks, Null mice exhibit significantly less Fos labeling than Wt in limbic cortices and subcortical structures, including key nodes in the default mode network. In contrast, Null mice exhibit significantly more Fos labeling than Wt in the hindbrain, most notably in cardiorespiratory regions of the nucleus tractus solitarius (nTS). Using nTS as a model, whole-cell recordings demonstrated that increased Fos expression in Nulls at 6 weeks of age is associated with synaptic hyperexcitability, including increased frequency of spontaneous and miniature EPSCs and increased amplitude of evoked EPSCs in Nulls. No such effect of genotype on Fos or synaptic function was seen at 3 weeks. In the mutant forebrain, reduced Fos expression, as well as abnormal sensorimotor function, were reversed by the NMDA receptor antagonist ketamine. In light of recent findings that the default mode network is hypoactive in autism, our data raise the possibility that hypofunction within this meta-circuit is a shared feature of RTT and other ASDs and is reversible.

18 March 2015 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
MGMarie A. Gadziola
Marie A. Gadziola
KTKate A. Tylicki
Kate A. Tylicki
DCDiana L. Christian
Diana L. Christian
DWDaniel W. Wesson
Daniel W. Wesson
Sensory information acquires meaning to adaptively guide behaviors. Despite odors mediating a number of vital behaviors, the components of the olfactory system responsible for assigning meaning to odors remain unclear. The olfactory tubercle (OT), a ventral striatum structure that receives monosynaptic input from the olfactory bulb, is uniquely positioned to transform odor information into behaviorally relevant neural codes. No information is available, however, on the coding of odors among OT neurons in behaving animals. In recordings from mice engaged in an odor discrimination task, we report that the firing rate of OT neurons robustly and flexibly encodes the valence of conditioned odors over identity, with rewarded odors evoking greater firing rates. This coding of rewarded odors occurs before behavioral decisions and represents subsequent behavioral responses. We predict that the OT is an essential region whereby odor valence is encoded in the mammalian brain to guide goal-directed behaviors.

31 January 2018 in Cancer Research
Verified
Journal Article
Closed access
PDF file
AGAaron J Grossberg
Aaron J Grossberg
Elisabeth VichayaElisabeth Vichaya
Elisabeth Vichaya
DCDiana L. Christian
Diana L. Christian
JMJessica Molkentine
Jessica Molkentine
DVDaniel W. Vermeer
Daniel W. Vermeer
RDRobert Dantzer
Robert Dantzer
Fatigue is the most common symptom of cancer at diagnosis, yet causes and effective treatments remain elusive. As tumors can be highly inflammatory, it is generally accepted that inflammation mediates cancer-related fatigue. However, evidence to support this assertion is mostly correlational. In this study, we directly tested the hypothesis that fatigue results from propagation of tumor-induced inflammation to the brain and activation of the central proinflammatory cytokine, IL1. The heterotopic syngeneic murine head and neck cancer model (mEER) caused systemic inflammation and increased expression of Il1b in the brain while inducing fatigue-like behaviors characterized by decreased voluntary wheel running and exploratory activity. Expression of Il1b in the brain was not associated with any alterations in motivation, measured by responding in a progressive ratio schedule of food reinforcement, depression-like behaviors, or energy balance. Decreased wheel running occurred prior to Il1b detection in the brain, when systemic inflammation was minimal. Furthermore, mice null for two components of IL1β signaling, the type 1 IL1 receptor or the receptor adapter protein MyD88, were not protected from tumor-induced decreases in wheel running, despite attenuated cytokine action and expression. Behavioral and inflammatory analysis of four additional syngeneic tumor models revealed that tumors can induce fatigue regardless of their systemic or central nervous system inflammatory potential. Together, our results show that brain IL1 signaling is not necessary for tumor-related fatigue, dissociating this type of cancer sequela from systemic cytokine expression. Significance: These findings challenge the current understanding of fatigue in cancer patients, the most common and debilitating sequela associated with malignancy. Cancer Res; 78(3); 695–705. ©2017 AACR.

27 April 2018 in Neuropsychopharmacology
Verified
Journal Article
Closed access
PDF file
Elisabeth VichayaElisabeth Vichaya
Elisabeth Vichaya
Geoffroy LaumetGeoffroy Laumet
Geoffroy Laumet
DCDiana L. Christian
Diana L. Christian
AGAaron J Grossberg
Aaron J Grossberg
DEDarlene J. Estrada
Darlene J. Estrada
RDRobert Dantzer
Robert Dantzer

1 May 2017 in Psychoneuroendocrinology
Verified
Journal Article
Closed access
Elisabeth VichayaElisabeth Vichaya
Elisabeth Vichaya
DVDaniel W. Vermeer
Daniel W. Vermeer
DCDiana L. Christian
Diana L. Christian
JMJessica Molkentine
Jessica Molkentine
KMKathy A. Mason
Kathy A. Mason
RDRobert Dantzer
Robert Dantzer